GSK Investigational Site

Bend, Oregon 97701

0 studies enrolling now · 11 studies all time

What they study most

Asthma, Diabetes Mellitus, Type 2, Hypertension, Lung Cancer, Non-Small Cell, Neoplasms, Breast, Pulmonary Disease, Chronic Obstructive, Sepsis, Thrombocytopaenia

Studies at this site

• Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer — Stopped early
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease — Completed
• A Study In Patients With Type 2 Diabetes Mellitus — Completed
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide — Completed
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults — Completed
• Study Of Allergic Rhinitis In Patients Who Also Have Asthma — Completed
• Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only — Completed
• Advair Pediatric Once-Daily — Completed
• Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag — Completed
• Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension — Completed